We suggest that SOCS5 acts as a central switch point, with changes in SOCS5 levels and/or activity impacting disease outcome in individuals such as those with COPD, who exhibit increased susceptibility to influenza. This evidence concerns the gene SOCS5 and chronic obstructive pulmonary disease.